Is Fresh2 Group Limited American Depositary Shares a good investment? Fresh2 Group Limited American Depositary Shares (FRES) is currently trading at 0.8500 USD.
No, it does not currently pay a dividend.
Fresh2 Group Limited American Depositary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
| Split Date | Split Ratio to 1 |
|---|---|
| July 10, 2024 | 0.100000 |
| Nov. 4, 2022 | 0.050000 |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion